在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

ERG Antibody

  • 中文名稱:
    ERG兔多克隆抗體
  • 貨號:
    CSB-PA007781HA01HU
  • 規格:
    ¥440
  • 圖片:
    • Immunoprecipitating ERG in Rat heart tissue
      Lane 1: Rabbit control IgG (1µg) instead of CSB-PA007781HA01HU in Rat heart tissue. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000)
      Lane 2: CSB-PA007781HA01HU (8µg) + Rat heart tissue (500µg)
      Lane 3: Rat heart tissue (10µg)
    • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA007781HA01HU at dilution of 1:100
    • Immunofluorescent analysis of PC-3 cells using CSB-PA007781HA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) ERG Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 別名:
    Avian erythroblastosis virus E-26 (v-ets) oncogene related antibody; D030036I24Rik antibody; Erg 3 antibody; Erg antibody; ERG/EWS fusion gene; included antibody; ERG/FUS fusion gene; included antibody; ERG/TMPSSR2 fusion gene; included antibody; ERG_HUMAN antibody; ERG1; included antibody; ERG2; included antibody; ets related antibody; ETS-related gene antibody; KCNH2 antibody; Oncogene ERG antibody; p55 antibody; TMPRSS2/ERG fusion antibody; transcriptional regulator ERG (transforming protein ERG) antibody; Transcriptional regulator ERG antibody; Transforming protein ERG antibody; v ets avian erythroblastosis virus E26 oncogene antibody; v ets avian erythroblastosis virus E26 oncogene related antibody; v ets erythroblastosis virus E26 oncogene homolog antibody; v ets erythroblastosis virus E26 oncogene like antibody; v ets erythroblastosis virus E26 oncogene like isoform 2 antibody; v-ets erythroblastosis virus E26 oncogene antibody; v-ets erythroblastosis virus E26 oncogene homolog (avian) antibody; V-ets erythroblastosis virus E26 oncogene like (Avian); isoform CRA_e antibody
  • 宿主:
    Rabbit
  • 反應種屬:
    Human, Rat
  • 免疫原:
    Recombinant Human Transcriptional regulator ERG protein (1-486AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated

    本頁面中的產品,ERG Antibody (CSB-PA007781HA01HU),的標記方式是Non-conjugated。對于ERG Antibody,我們還提供其他標記。見下表:

    可提供標記
    標記方式 貨號 產品名稱 應用
    HRP CSB-PA007781HB01HU ERG Antibody, HRP conjugated ELISA
    FITC CSB-PA007781HC01HU ERG Antibody, FITC conjugated
    Biotin CSB-PA007781HD01HU ERG Antibody, Biotin conjugated ELISA
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA, IHC, IF, IP
  • 推薦稀釋比:
    Application Recommended Dilution
    IHC 1:20-1:200
    IF 1:50-1:200
    IP 1:200-1:2000
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Transcriptional regulator. May participate in transcriptional regulation through the recruitment of SETDB1 histone methyltransferase and subsequent modification of local chromatin structure.
  • 基因功能參考文獻:
    1. endothelial transcriptional effector activated downstream of Ang1 to promote Notch signalling and vascular stability PMID: 28695891
    2. Nine primary prostate cancers that developed metachronous bone metastasis samples showed TMPRSS2-ERG fusions, which were associated with increased ERG expression at immunohistochemistry. mTOR pathway activation was documented in 6 patients PMID: 30190183
    3. Data indicate a significant prognostic role for assessing transcriptional regulator ERG (ERG) and phosphatase and tensin homolog protein (PTEN) in men with prostate cancer. PMID: 30101374
    4. There was no statistically significant difference in the expression of the ERG between patients and controls. Also, no correlation was detected between the expression of this gene and age of onset, disease duration and Expanded Disability Status Scale. PMID: 29488813
    5. Here, the authors show that ERG, through its physical interaction with androgen receptor, induces AR aggregation and endoplasmic reticulum stress in the prostate glands of ERG transgenic mice. PMID: 28439080
    6. Our results suggested that reduced expression of miR-1271 may be involved in the ERG expression and that miR-1271 could be a therapeutic target for ERG-positive prostate cancer patients PMID: 28551819
    7. Evaluating the association between ERG expression and pathologic factors. PMID: 29948147
    8. despite of their well-known adverse role in prognosis of AML, neither BAALC nor ERG expression levels at diagnosis had effect on survival of AML patients who underwent allo-HSCT. PMID: 29696374
    9. ERG expression is lost in liver endothelial cells from cirrhotic patients with fibrosis related to alcoholic liver disease or primary biliary cirrhosis and inversely correlates with increased markers of endothelial-to-mesenchymal transition. PMID: 29026072
    10. ERG expression is of limited prognostic value in acute myeloid leukemia. PMID: 27935581
    11. Our findings indicate that TGF-beta signaling is a major determinant of EMT in T/E overexpressing LNCaP cells. PMID: 28445989
    12. Findings reveal that PCa-associated ERG can interact and co-occupy with BRD4 in the genome, and suggest this druggable interaction is critical for ERG-mediated cell invasion and PCa progression. PMID: 27223260
    13. this work provides novel insights in the regulation of ERG protein stability in prostate cancer PMID: 27626314
    14. Study reveals that miR-200b/a/429 is an ERG target gene, which implicates an important role in TMPRSS2/ERG-dependent PCa development. PMID: 27191272
    15. ERG and SOX9 are potential biomarkers for prediction of response to docetaxel treatment in metastatic castration-resistant prostate cancer patients. PMID: 27863438
    16. A potential novel function of TMPRSS2-ERG as a major regulator of IGF1R gene expression. PMID: 27285981
    17. Study shows that T2E fusion transcripts are associated with higher levels of AMACR mRNA in patients with atypical small acinar proliferation (ASAP) which represents an indicator of risk for prostate cancer in patients with ASAP. PMID: 29277318
    18. TMPRSS2-ERG may have a role in progression of prostate neoplasms and in alteration of the metabolic profile PMID: 27276682
    19. Detection of TMPRSS2-ERG in blood from Metastatic Resistant Prostate Cancer patients predicts resistance to docetaxel and it may be useful to select treatment and to avoid possible toxicities in refractory patients.TMPRSS2-ERG-positive patients had more adverse prognostic factors compared with TMPRSS2-ERG-negative. PMID: 26948395
    20. Meta-analysis showed the prevalence of TMPRSS2:ERG fusions in prostate cancer to be highest in men of European descent (49%), followed by Asians (27%) and then African (25%) descent. PMID: 28633309
    21. Data show that tumors displaying TMPRSS2-ERG fusions that retained interstitial genes were less likely to be associated with biochemical recurrence PMID: 29127096
    22. ERG, FLI1, TAL1, and RUNX1 bind at all AML1-ETO-occupied regulatory regions, including those of the AML1-ETO gene itself, suggesting their involvement in regulating AML1-ETO expression levels. PMID: 27851970
    23. four oncogenic ETS (ERG, ETV1, ETV4, and ETV5), and no other ETS, interact with the Ewing's sarcoma breakpoint protein, EWS. PMID: 27783944
    24. We demonstrate a role for inflammation-induced oxidative stress in the formation of DNA breaks leading to recurrent TMPRSS2-ERG gene fusions. The transcriptional status and epigenetic features of the target genes influence this effect. PMID: 27926866
    25. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the androgen receptor. PMID: 27183006
    26. NOTCH pathway inhibition antagonizes the growth and invasion of transmembrane protease serine 2 (TMPRSS2)-transforming protein ERG (ERG) (T2E) -positive prostate cancer cells. PMID: 28783165
    27. findings have identified critical molecular mechanisms involving ERK-mediated ERG activation that could be exploited for therapeutic intervention in ERG-positive prostate cancers. PMID: 28887309
    28. Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer.( PMID: 28560674
    29. The TMPRSS2-ERG gene fusion is the most frequently observed genetic aberration in Prostate cancer. PMID: 28845585
    30. Loss of ERG is associated with prostate tumors. PMID: 28186998
    31. Data show that homogeneous ERG positivity is very rare in prostate cancer, especially in elderly patients. However, development of subpopulations with ERG fusions may be a much more frequent event in ERG negative cancer foci as previously believed. PMID: 27530104
    32. Genome-wide gene expression profiling identified a network of VEGF-responsive and ERG-dependent genes. PMID: 28536097
    33. ERG deletion is associated with acute lymphoblastic leukemia. PMID: 27776115
    34. Study provide evidence that PTEN deletion and TMPRSS2-ERG gene fusion were mutually exclusive in patients with prostate neoplasm. TMPRSS2-ERG gene fusion was rare compared to peripheral zone tumors and to PTEN inactivation in T1a transition zone tumors. PMID: 27500376
    35. ERG rearrangement, but not PTEN loss, is present in a minority of potential neoplastic precursor lesions in the prostate. PMID: 27189342
    36. Patients with Prostate cancer had significantly higher levels of the prostate cancer-associated gene ERG in post-digital rectal examination urine extracellular vesicles. Continued analysis of urine EVs offers the potential discovery of novel biomarkers for pre-biopsy Prostate cancer detection. PMID: 28419548
    37. loss of ERG and FLI1 might contribute to the pathogenesis of vascular lung complications through the induction of inflammation. PMID: 28248553
    38. Neither the expression of aberrant proteins from internally deleted allele nor the reduced expression of wild type ERG seem to provide a plausible explanation of the specific biology of ERG -related leukemia subgroup. PMID: 27494621
    39. Our results suggest that the immune response may differ between ERG negative and ERG positive prostatic carcinomas PMID: 28547958
    40. identified five phosphorylated serines on endogenous ERG in T-ALL and AML cells. PMID: 27055868
    41. miR-204 upregulates androgen receptor (AR ) and downregulates TMPRSS2/ERG through direct regulation of their promoter methylation and set of transcription factors during AR cancer-related reprogramming. PMID: 28050800
    42. differential expression of TMPRSS2:ERG in urine exosomes in prostate cancer and controls PMID: 27144529
    43. SPINK1 and ERG expressions are exclusive events in PCA. PMID: 27738792
    44. This study focused on the clinical application value of ERG methylation level in blood of pregnant women as a biomarker in Down's syndrome. PMID: 28111453
    45. ETV6 and IKZF1 are transcriptional regulators not just of ERG, but also of a number of genes regulated by a densely interconnected network of seven transcription factors. PMID: 27604872
    46. Among 98 selected prostate carcinoma biopsies, 57 showed positive and 41 negative ERG staining. PMID: 28384107
    47. The present study established evidence for the first two common PrCa risk variants differentially associated with TMPRSS2:ERG fusion status. TMPRSS2:ERG phenotyping of larger studies is required to determine comprehensive sets of variants with subtype-specific roles in prostate cancer. PMID: 27798103
    48. ERG is recruited to mRNAs via interaction with the RNA-binding protein RBPMS, and it promotes mRNA decay by binding CNOT2, a component of the CCR4-NOT deadenylation complex. PMID: 27273514
    49. Concurrent nuclear ERG and MYC protein overexpression is common in prostate cancer and defines a subset of locally advanced tumors. PMID: 27159573
    50. Studies indicate that TMPRSS2-ERG fusion gene positive prostate cancers cells rewire intracellular signaling cascades and modulate gene and protein network. PMID: 28364793

    顯示更多

    收起更多

  • 相關疾?。?/div>
    Ewing sarcoma (ES)
  • 亞細胞定位:
    Nucleus. Cytoplasm. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.
  • 蛋白家族:
    ETS family
  • 數據庫鏈接:

    HGNC: 3446

    OMIM: 165080

    KEGG: hsa:2078

    STRING: 9606.ENSP00000381891

    UniGene: Hs.473819



主站蜘蛛池模板: 色婷婷久久久swag精品| 护士人妻hd中文字幕| 特级做a爰片毛片免费看无码| 日本一二三区视频在线| 无码中文av有码中文av| 最新版天堂资源中文官网| 激情文学小说区另类小说同性 | 无码专区—va亚洲v专区| 乱人伦人妻精品一区二区| 男ji大巴进入女人的视频小说| 国内精品国语自产拍在线观看| 亚洲国产精品一区二区制服| 亚洲色丰满少妇高潮18p| 五十老熟妇乱子伦免费观看| 久久无码无码久久综合综合| 2021亚洲国产成a在线| 成人无码免费一区二区三区| 亚洲乱亚洲乱妇24p| a v 在线视频 亚洲免费| 在线а√天堂中文官网| 老熟女重囗味hdxx69| 强被迫伦姧惨叫人妻系列| 久9视频这里只有精品试看| 无码人妻丰满熟妇啪啪欧美| 久久99精品国产麻豆婷婷| 亚洲午夜无码久久yy6080| 久久精品国产久精久精| 国产成人免费无码视频在线观看 | 国产69精品久久久久久久| 三级成年网站在线观看级爱网 | 成人性做爰aaa片免费| 国产精品国产三级国产aⅴ下载 | 天堂av色综合久久天堂| 日本中文字幕亚洲乱码| 午夜理论片yy44880影院| 草草影院精品一区二区三区 | 少妇被爽到高潮喷水久久欧美精品 | 国产精品xxx在线| 国产在线精品一区二区在线看| 国产av天堂亚洲国产av下载| 色婷婷综合中文久久一本 |